机译:急性淋巴细胞白血病治疗期间儿科患者延迟消除高剂量甲氨蝶呤和羧肽酶G2的使用
Department of PediatricsSahlgrenska Academy University of GothenburgGothenburg Sweden;
Department of PediatricsSahlgrenska Academy University of GothenburgGothenburg Sweden;
Department of Women's and Children's HealthKarolinska Institutet and Astrid Lindgren Children's;
Pediatric Department St. Olavs HospitalTrondheim University HospitalTrondheim Norway;
Children's HospitalHelsinki University Central Hospital and University of HelsinkiHelsinki Finland;
Children's HospitalLandspítali University HospitalReykjavik Iceland;
Children's HospitalAffiliate of Vilnius University Hospital Santariskiu Klinikos and Vilnius;
Department of PediatricsAarhus UniversityDenmark;
Department of Pediatrics and Adolescent MedicineRigshospitaletCopenhagen Denmark;
Department of PediatricsSk?ne University HospitalLund Sweden;
ALL; children; delayed methotrexate elimination; glucarpidase;
机译:急性淋巴细胞白血病治疗期间儿科患者延迟消除高剂量甲氨蝶呤和羧肽酶G2的使用
机译:甲氨蝶呤大剂量治疗后延迟氨甲蝶呤消除的癌症患者的羧肽酶-G2抢救。
机译:小剂量甲氨蝶呤在儿科急性淋巴细胞白血病:延迟间隙的预测因子及水合率增加对甲氨蝶呤的影响
机译:未定目标的代谢组学的干血斑代谢组揭示了与小儿急性淋巴细胞白血病相关的出生时的脂质调节。
机译:天冬酰胺酶对小儿急性淋巴细胞白血病患者的不良影响。
机译:甲氨蝶呤转运蛋白的多态性及其与血浆甲氨蝶呤水平高剂量甲氨蝶呤的毒性以及小儿急性淋巴细胞白血病的结局的关系
机译:小剂量甲氨蝶呤在儿科急性淋巴细胞白血病:延迟间隙的预测因子及水合率增加对甲氨蝶呤的影响